TrialBritish journal of cancer2016

Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.

Changhoon Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.